Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor

被引:0
|
作者
Eric D. Tetzlaff
Jaffer A. Ajani
机构
[1] The University of Texas M.D. Anderson Cancer Center,Department of Gastrointestinal Oncology and Digestive Systems
来源
关键词
Carcinoid; chromogranin A; interferon alpha; octreotide; oxaliplatin;
D O I
10.1385/IJGC:36:1:055
中图分类号
学科分类号
摘要
Carcinoid tumors are rare and often resistant to chemotherapy agents. Although a slow-growing tumor, patients can have significant morbidity associated with carcinoid syndrome and patients will often die as a result of tumor progression. We report the first case of a patient with a metastatic carcinoid tumor to respond to an oxaliplatin-based regimen. Further studies are needed to validate this observation.
引用
收藏
页码:55 / 58
页数:3
相关论文
共 50 条
  • [41] Bimonthly Chemotherapy with Oxaliplatin, Irinotecan, Infusional 5-Fluorouracil/Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with Irinotecan- or Oxaliplatin-Based Chemotherapy
    Nobili, S.
    Checcacci, D.
    Filippelli, F.
    Del Buono, S.
    Mazzocchi, V.
    Mazzei, T.
    Mini, E.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 622 - 631
  • [42] Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer
    Huang, Xiaoquan
    Li, Feng
    Wang, Lifen
    Xiao, Mei
    Ni, Liyuan
    Jiang, Siyu
    Ji, Yuan
    Zhang, Chunqing
    Zhang, Wei
    Wang, Jian
    Chen, Shiyao
    ENDOSCOPY, 2020, 52 (09) : 727 - 735
  • [43] phase II study of oxaliplatin-based regimen in relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: INSPIRE study
    Kotaka, M.
    Ishibashi, K.
    Satake, H.
    Tsuji, Y.
    Kataoka, M.
    Nakamura, M.
    Nagata, N.
    Sakamoto, J.
    Oba, K.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S101 - S101
  • [44] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Keiichiro Ishibashi
    Toru Aoyama
    Masahito Kotaka
    Hironaga Satake
    Yasushi Tsuji
    Masato Kataoka
    Masato Nakamura
    Naoki Nagata
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 665 - 672
  • [45] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    L Paré-Brunet
    A Sebio
    J Salazar
    A Berenguer-Llergo
    E Río
    A Barnadas
    M Baiget
    D Páez
    The Pharmacogenomics Journal, 2015, 15 : 397 - 404
  • [46] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Pare-Brunet, L.
    Sebio, A.
    Salazar, J.
    Berenguer-Llergo, A.
    Rio, E.
    Barnadas, A.
    Baiget, M.
    Paez, D.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (05): : 397 - 404
  • [47] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Ishibashi, Keiichiro
    Aoyama, Toru
    Kotaka, Masahito
    Satake, Hironaga
    Tsuji, Yasushi
    Kataoka, Masato
    Nakamura, Masato
    Nagata, Naoki
    Sakamoto, Junichi
    Oba, Koji
    Mishima, Hideyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (05) : 665 - 672
  • [48] Splenomegaly during oxaliplatin-based chemotherapy: impact on blood parameters and anti-neoplastic treatment
    Ji, Ruoyu
    Huang, Guanghua
    Xu, Jing
    Yu, Xiaoduo
    Zhou, Aiping
    Du, Chunxia
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) : 1880 - 1888
  • [49] New biomarkers to predict response to oxaliplatin-based chemotherapy in metastatic colorectal cancer: KRAS and ERCC1.
    Strippoli, Antonia
    Basso, Michele
    Orlandi, Armando
    Schinzari, Giovanni
    Calegari, Alessandra
    Cursio, Olga Elisabetta
    Barile, Rosalba
    Amoruso, Alessia
    Pozzo, Carmelo
    Cassano, Alessandra
    Barone, Carlo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [50] Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
    Yamamoto, Seiji
    Fujii, Hironori
    Murayama, Kotaro
    Iihara, Hirotoshi
    Watanabe, Daichi
    Yamada, Yunami
    Kobayashi, Ryo
    Kiyama, Shigeru
    Makiyama, Akitaka
    Urano, Kimihiko
    Matsuhashi, Nobuhisa
    Matsuura, Katsuhiko
    Suzuki, Akio
    ANTICANCER RESEARCH, 2023, 43 (11) : 5099 - 5105